Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers
The safety, tolerability, and pharmacokinetics(PK)/pharmacodynamics (PD) of DA-3031 (PEG-G-CSF) following a single dose delivered by subcutaneous (SC) injection were investigated in healthy volunteers. PK/PD of filgrastim (Dong-A) following repeated dose delivered by SC injection were investigated in healthy volunteers. PK/PD from a single dose of DA-3031 and repeated dose of filgrastim (Dong-A) were compared.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00959777
|Korea, Republic of|
|Clinical Trials center, Clinical Research institute, Seoul National University Hospital|
|Seoul, Yonggon-Dong, Chongono-Gu, Korea, Republic of, 110-744|